A new test can identify patients with multiple myeloma (MM) who have a high-risk genetic profile as well as multiple chromosomal abnormalities. In this subgroup of patients with ultra-high-risk MM, disease progression is increased, survival is very poor, and it is unlikely that patients will respond to a commonly used maintenance therapy, British researchers report.
Genetic Test Identifies Ultra-High-Risk Myeloma Patients
